Nanovibronix Stock Fundamentals
| NAOV Stock | USD 0.81 0.01 1.22% |
NanoVibronix fundamentals help investors to digest information that contributes to NanoVibronix's financial success or failures. It also enables traders to predict the movement of NanoVibronix Stock. The fundamental analysis module provides a way to measure NanoVibronix's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to NanoVibronix stock.
At this time, NanoVibronix's Depreciation And Amortization is fairly stable compared to the past year. Total Revenue is likely to climb to about 2.4 M in 2024, whereas Selling General Administrative is likely to drop slightly above 2.4 M in 2024. NanoVibronix | Select Account or Indicator |
NanoVibronix Company Return On Equity Analysis
NanoVibronix's Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Current NanoVibronix Return On Equity | -1.03 |
Most of NanoVibronix's fundamental indicators, such as Return On Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, NanoVibronix is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
For most industries, Return on Equity between 10% and 30% are considered desirable to provide dividends to owners and have funds for the future growth of the company. Investors should be very careful using ROE as the only efficiency indicator because ROE can be high if a company is heavily leveraged.
| Competition |
NanoVibronix Total Stockholder Equity
Total Stockholder Equity |
|
Based on the latest financial disclosure, NanoVibronix has a Return On Equity of -1.0278. This is 95.71% lower than that of the Health Care Equipment & Supplies sector and 88.23% lower than that of the Health Care industry. The return on equity for all United States stocks is notably higher than that of the company.
NanoVibronix Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining NanoVibronix's current stock value. Our valuation model uses many indicators to compare NanoVibronix value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across NanoVibronix competition to find correlations between indicators driving NanoVibronix's intrinsic value. More Info.NanoVibronix is considered to be number one stock in return on equity category among related companies. It is considered to be number one stock in return on asset category among related companies . At this time, NanoVibronix's Return On Equity is fairly stable compared to the past year.Comparative valuation analysis is a catch-all model that can be used if you cannot value NanoVibronix by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for NanoVibronix's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the NanoVibronix's earnings, one of the primary drivers of an investment's value.NanoVibronix Return On Equity Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses NanoVibronix's direct or indirect competition against its Return On Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of NanoVibronix could also be used in its relative valuation, which is a method of valuing NanoVibronix by comparing valuation metrics of similar companies.NanoVibronix is currently under evaluation in return on equity category among related companies.
NanoVibronix Fundamentals
| Return On Equity | -1.03 | ||||
| Return On Asset | -0.31 | ||||
| Profit Margin | (1.63) % | ||||
| Operating Margin | (0.29) % | ||||
| Current Valuation | (1.3 M) | ||||
| Shares Outstanding | 2.78 M | ||||
| Shares Owned By Insiders | 0.42 % | ||||
| Shares Owned By Institutions | 13.06 % | ||||
| Number Of Shares Shorted | 16.35 K | ||||
| Price To Earning | (5.34) X | ||||
| Price To Book | 0.53 X | ||||
| Price To Sales | 0.93 X | ||||
| Revenue | 2.28 M | ||||
| Gross Profit | 167 K | ||||
| EBITDA | (3.44 M) | ||||
| Net Income | (3.71 M) | ||||
| Cash And Equivalents | 3.94 M | ||||
| Cash Per Share | 0.14 X | ||||
| Total Debt | 5 K | ||||
| Debt To Equity | 0.01 % | ||||
| Current Ratio | 3.07 X | ||||
| Book Value Per Share | 1.95 X | ||||
| Cash Flow From Operations | (3.6 M) | ||||
| Short Ratio | 0.14 X | ||||
| Earnings Per Share | (1.68) X | ||||
| Target Price | 10.5 | ||||
| Number Of Employees | 10 | ||||
| Beta | 1.3 | ||||
| Market Capitalization | 2.36 M | ||||
| Total Asset | 6.67 M | ||||
| Retained Earnings | (66.1 M) | ||||
| Working Capital | 4.03 M | ||||
| Current Asset | 1.78 M | ||||
| Current Liabilities | 297 K | ||||
| Net Asset | 6.67 M |
About NanoVibronix Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze NanoVibronix's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of NanoVibronix using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of NanoVibronix based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 46 K | 43.7 K | |
| Total Revenue | 2.3 M | 2.4 M | |
| Cost Of Revenue | 746 K | 783.3 K | |
| Stock Based Compensation To Revenue | 0.13 | 0.12 | |
| Sales General And Administrative To Revenue | 1.72 | 1.63 | |
| Research And Ddevelopement To Revenue | 0.08 | 0.08 | |
| Capex To Revenue | (0.0004) | (0.0005) | |
| Revenue Per Share | 1.30 | 1.25 | |
| Ebit Per Revenue | (1.51) | (1.58) |
Pair Trading with NanoVibronix
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if NanoVibronix position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NanoVibronix will appreciate offsetting losses from the drop in the long position's value.Moving together with NanoVibronix Stock
| 0.84 | AHG | Akso Health Group | PairCorr |
| 0.83 | CAH | Cardinal Health Fiscal Year End 20th of August 2024 | PairCorr |
Moving against NanoVibronix Stock
| 0.72 | WGS | GeneDx Holdings Corp | PairCorr |
| 0.7 | GCTK | GlucoTrack | PairCorr |
| 0.63 | ESTA | Establishment Labs | PairCorr |
| 0.47 | INGN | Inogen Inc | PairCorr |
| 0.45 | NXL | Nexalin Technology | PairCorr |
The ability to find closely correlated positions to NanoVibronix could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace NanoVibronix when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back NanoVibronix - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling NanoVibronix to buy it.
The correlation of NanoVibronix is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NanoVibronix moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NanoVibronix moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for NanoVibronix can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out NanoVibronix Piotroski F Score and NanoVibronix Altman Z Score analysis. For more information on how to buy NanoVibronix Stock please use our How to Invest in NanoVibronix guide.You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Complementary Tools for NanoVibronix Stock analysis
When running NanoVibronix's price analysis, check to measure NanoVibronix's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NanoVibronix is operating at the current time. Most of NanoVibronix's value examination focuses on studying past and present price action to predict the probability of NanoVibronix's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NanoVibronix's price. Additionally, you may evaluate how the addition of NanoVibronix to your portfolios can decrease your overall portfolio volatility.
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Stocks Directory Find actively traded stocks across global markets | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |
Is NanoVibronix's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NanoVibronix. If investors know NanoVibronix will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NanoVibronix listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.68) | Revenue Per Share 1.304 | Quarterly Revenue Growth 3.722 | Return On Assets (0.31) | Return On Equity (1.03) |
The market value of NanoVibronix is measured differently than its book value, which is the value of NanoVibronix that is recorded on the company's balance sheet. Investors also form their own opinion of NanoVibronix's value that differs from its market value or its book value, called intrinsic value, which is NanoVibronix's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NanoVibronix's market value can be influenced by many factors that don't directly affect NanoVibronix's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NanoVibronix's value and its price as these two are different measures arrived at by different means. Investors typically determine if NanoVibronix is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NanoVibronix's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.